{"SPADE_UN_16215": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16215", "Peptide Name": "LTX-315 Metabolites 3", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "WKKWXK", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A20 (IC50=247 ± 13 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "MRC-5:IC50=460 ± 71 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C40H56N10O5", "Mass": 95631, "PI": 11.1, "Net Charge": 3, "Hydrophobicity": -2.25, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide", "Pubmed ID": "26982623", "Reference": "J Med Chem. 2016 Apr 14;59(7)2918-27.", "Author": "Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26982623"}], "Frequent Amino Acids": "KWX", "Absent Amino Acids": "ACDEFGHILMNOPQRSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 3, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02388", "Similarity": 1.0, "Sequence": "IDWKKVDWKKVSKKTCKVMLKACKFL"}, {"SPADE_ID": "SPADE_N_06732", "Similarity": 1.0, "Sequence": "KWKKLAKKW"}, {"SPADE_ID": "SPADE_N_06966", "Similarity": 1.0, "Sequence": "RQIKIWFQNRRMAWKK"}]}}}